Tirzepatide GLP-1/GIP option commonly associated with Mounjaro and Zepbound
Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, et al
Fatima Cody Stanford, an instructor of medicine and pediatrics at Harvard Medical School and obesity medicine physician at Massachusetts General Hospital, tells Yahoo Life
Diarrhea during GLP-1 therapy is not a sign of medication failure or that you cannot tolerate the drugit is a normal physiological response that typically resolves as your body acclimates
Source: Hwang, et al JAMA Health Forum March 14, 2025 Implications for employers: This modeled study suggests that employers should at least offer access to the two combination generic medications for obesity if budgets allow